Articles with public access mandates - Thomas BaumertLearn more
Not available anywhere: 22
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
AJ Syder, H Lee, MB Zeisel, J Grove, E Soulier, J Macdonald, S Chow, ...
Journal of hepatology 54 (1), 48-55, 2011
Mandates: US National Institutes of Health
Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection
RC Hoogeveen, MP Robidoux, T Schwarz, L Heydmann, JA Cheney, ...
Gut 68 (5), 893-904, 2019
Mandates: US National Institutes of Health, Royal Netherlands Academy of Arts and Sciences
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication
K Himmelsbach, D Sauter, TF Baumert, L Ludwig, HE Blum, E Hildt
Gut 58 (12), 1644-1653, 2009
Mandates: German Research Foundation
Virus–host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies
P Georgel, C Schuster, MB Zeisel, F Stoll-Keller, T Berg, S Bahram, ...
Trends in molecular medicine 16 (6), 277-286, 2010
Mandates: National Institute of Health and Medical Research, France
TIP47 plays a crucial role in the life cycle of hepatitis C virus
D Ploen, ML Hafirassou, K Himmelsbach, D Sauter, ML Biniossek, ...
Journal of hepatology 58 (6), 1081-1088, 2013
Mandates: National Institute of Health and Medical Research, France
Entry of hepatitis B and C viruses—recent progress and future impact
TF Baumert, L Meredith, Y Ni, DJ Felmlee, JA McKeating, S Urban
Current opinion in virology 4, 58-65, 2014
Mandates: German Research Foundation, UK Medical Research Council
Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication
YX Wang, M Niklasch, T Liu, Y Wang, B Shi, W Yuan, TF Baumert, Z Yuan, ...
Journal of hepatology 72 (5), 865-876, 2020
Mandates: National Natural Science Foundation of China
Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential
J Jo, B Bengsch, B Seigel, SJ Rau, J Schmidt, E Bisse, P Aichele, ...
Journal of hepatology 57 (1), 9-16, 2012
Mandates: German Research Foundation
Host cell kinases and the hepatitis C virus life cycle
CC Colpitts, J Lupberger, C Doerig, TF Baumert
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1854 (10), 1657-1662, 2015
Mandates: National Institute of Health and Medical Research, France
Entry inhibitors and future treatment of hepatitis C
I Fofana, N Jilg, RT Chung, TF Baumert
Antiviral research 104, 136-142, 2014
Mandates: National Institute of Health and Medical Research, France, European Commission
Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection
S Pfeffer, TF Baumert
Gastroenterologie clinique et biologique 34 (8-9), 431-435, 2010
Mandates: National Institute of Health and Medical Research, France
High-throughput approaches to unravel hepatitis C virus-host interactions
CC Colpitts, H El-Saghire, N Pochet, C Schuster, TF Baumert
Virus research 218, 18-24, 2016
Mandates: US National Institutes of Health
Class a capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation
DB Kum, H Vanrusselt, AA Sanchez, V Taverniti, ER Verrier, TF Baumert, ...
Hepatology 78 (4), 1252-1265, 2023
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort)
M Santos, C Protopopescu, E Delarocque‐Astagneau, M Bourlière, ...
Liver International 42 (1), 38-49, 2022
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
Differences between sporadic hyperplastic gastric polyps and portal hypertensive gastric polyps: a review
L Héroin, A Saviano, T Fenouil, L Sosa-Valencia, TF Baumert, ...
European Journal of Gastroenterology & Hepatology 34 (3), 260-266, 2022
Mandates: Agence Nationale de la Recherche
Tight junctions and viral entry
MB Zeisel, M Turek, TF Baumert
Future Virology 5 (3), 263-271, 2010
Mandates: National Institute of Health and Medical Research, France
Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients
C Moreau, M Roux, J Riou, CM Canivet, E Audureau, C Lusivika‐Nzinga, ...
Journal of Viral Hepatitis 30 (6), 567-577, 2023
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept
C Leboeuf, J Roser-Schilder, M Lambotin, S Durand, T Wu, C Fauvelle, ...
Gene Therapy 22 (2), 172-180, 2015
Mandates: National Institute of Health and Medical Research, France
Targeting the liver clock improves fibrosis by restoring TGF-β signaling
E Crouchet, M Dachraoui, F Jühling, N Roehlen, MA Oudot, SC Durand, ...
Journal of hepatology, 2024
Mandates: European Commission, Agence Nationale de la Recherche
Immunomodulation and entry inhibition: selgantolimod’s double punch against hepatitis B virus
T Baumert, M Urbanek-Quaing, M Cornberg
Gut, 2024
Mandates: European Commission, Agence Nationale de la Recherche
Publication and funding information is determined automatically by a computer program